RAEDAWN MACKEY: Open Payments
NPI 1811478803 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,372 in 37 payments from 7 companies in 2025. Trend: 2023 $1,073 · 2024 $1,021 · 2025 $1,372
Food & beverage: $1,371Education: $1
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $713 |
| Janssen Pharmaceuticals, Inc | 6 | $241 |
| Vanda Pharmaceuticals Inc. | 8 | $201 |
| Collegium Pharmaceutical, Inc. | 1 | $122 |
| ABBVIE INC. | 4 | $61 |
| Corium, LLC | 1 | $18 |
| Lundbeck LLC | 1 | $15 |
Products named: REXULTI, ABILIFY MAINTENA, INVEGA, FANAPT, Jornay PM, VRAYLAR, SPRAVATO, Azstarys.
Industry payments across LA — which companies pay providers there.
